LISA DONOFRIO: Open Payments
NPI 1154933745 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,095 in 133 payments from 10 companies in 2025. Trend: 2023 $1,070 · 2024 $1,219 · 2025 $2,095
Food & beverage: $1,991Education: $104
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 30 | $579 |
| Teva Pharmaceuticals USA, Inc. | 24 | $458 |
| ABBVIE INC. | 26 | $309 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $223 |
| Neurocrine BioSciences, Inc. | 19 | $211 |
| Axsome Therapeutics, Inc. | 4 | $98 |
| Vanda Pharmaceuticals Inc. | 4 | $84 |
| Alkermes, Inc. | 3 | $69 |
| Lundbeck LLC | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
Products named: CAPLYTA, AUSTEDO XR, VRAYLAR, TRINTELLIX, INGREZZA, Auvelity, ARISTADA, HETLIOZ.
Industry payments across NY — which companies pay providers there.
